Congress trades in Danaher Corporation (DHR)
8 of the members we track disclosed 11 purchases of DHR between 2022-09-20 and 2026-03-27, and 12 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How DHR was classified.
How these buys are tagged
7 of these purchases were made by a member whose own committee oversees Healthcare & Pharma.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 11 | +2.4% | -1.8% | 45% |
| Notable (committee-flagged) | 7 | -0.9% | -4.8% | 29% |
| Unaligned (no committee overlap) | 4 | Too few buys to measure | ||
| Cluster, excl. mega-caps | 0 | Too few buys to measure | ||
| Not clustered, excl. mega-caps | 11 | +2.4% | -1.8% | 45% |
Who bought the most
- Thomas H. Kean, Jr. — 3 buys
- Dan Newhouse — 2 buys
- Alan Armstrong — 1 buy
- Julie Johnson — 1 buy
- Lisa C. McClain — 1 buy
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 2026-07-21 |
Notable | $181.52 | +5.3% | -2.4% | +8.1% | -3.8% |
| Julie Johnson | 2025-10-07 2025-11-14 |
Unaligned | $208.77 | -1.3% | +0.9% | +13.3% | +3.7% |
| Thomas H. Kean, Jr. | 2025-09-03 2025-10-14 |
Notable | $199.44 | -3.4% | +7.8% | +14.6% | +1.3% |
| Lisa C. McClain | 2025-07-22 2025-08-13 |
Unaligned | $189.91 | +8.9% | +7.4% | +16.2% | +7.6% |
| Thomas H. Kean, Jr. | 2025-06-11 2025-07-16 |
Notable | $204.72 | -5.0% | +0.1% | -5.9% | -7.1% |
| Julia Letlow | 2025-04-28 2026-01-13 |
Notable | $195.91 | +0.8% | -3.5% | +3.6% | +6.0% |
| Val T. Hoyle | 2024-10-29 2025-09-12 |
Unaligned | $242.69 | +3.0% | -1.6% | +2.1% | +3.4% |
| Dan Newhouse | 2024-04-10 2024-04-25 |
Notable | $245.87 | -2.6% | +3.1% | -1.5% | -4.8% |
| Markwayne Mullin | 2023-09-13 2023-10-12 |
Unaligned | $223.80 | +0.8% | -6.4% | +1.4% | -1.0% |
| Thomas H. Kean, Jr. | 2023-07-31 2023-09-18 |
Notable | $226.12 | +0.2% | +3.6% | -18.1% | -10.4% |
| Dan Newhouse | 2022-09-20 2023-05-26 |
Notable | $243.24 | -5.2% | -11.4% | -6.8% | -14.6% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 12 disclosed sales of DHR are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in DHR are a small part of the full rankings, which score each member across everything they bought.
Data last updated .